Title | Phase II Trial Testing the Antiemetic Efficacy of a Single-day Low Dose Aprepitant (or Fosaprepitant) Added to a 5-HT3 Receptor Antagonist Plus Dexamethasone in Patients Receiving Carboplatin |
---|---|
Disease/Condition | Oncology (Medical/Hematologic),Cancer |
Description | |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Richard Gralla, MD |
Contact Name | Karine Darbinyan |
Contact Email | kadarbin@montefiore.org |
Protocol Number | 2015-5109 |
Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
Status | Active/Enrolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |
Sub-Specialty | Medical and Hematologic Oncology |
Adult, Pediatric, Both | Adult |